Clinical Trial Update: Infliximab Proactive Drug Monitoring in the Pediatric IBD Population

View source ↗

Summary

Clinical trial update on proactive drug monitoring with infliximab in pediatric inflammatory bowel disease. The study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Cares, Kristen, M.D. | Conditions: Inflammatory Bone Disease | Status: ACTIVE_NOT_RECRUITING